1613192-01-0

Basic information

• Product Name: Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate
• Synonyms: Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate;tert-butyl 1-(3-amino-5-fluoro-4-pyridyl)piperidine-4-carboxylate;EOS-61442;Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate(WXC04787)
• CAS NO: 1613192-01-0
• Molecular Formula: C15H22FN3O2
• Molecular Weight: 295.3524832
• EINECS: -0
• Mol File: 1613192-01-0.mol

Chemical Properties

• Boiling Point: 418.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.188±0.06 g/cm3(Predicted)
• PKA: 9.48±0.30(Predicted)
• CAS DataBase Reference: Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate(1613192-01-0)
• EPA Substance Registry System: Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate(1613192-01-0)

Safety Data

• Hazardous Substances Data: 1613192-01-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate is used as a potential pharmaceutical compound for its diverse functional groups that may contribute to the development of new drugs. The presence of the amino and fluoropyridine moieties could be exploited in the design of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical field, Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate is used as a potential active ingredient in the development of new pesticides or herbicides. Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate's structure may offer unique properties that could be harnessed to control agricultural pests or weeds more effectively.
Used in Materials Science:
Tert-Butyl 1-(3-Amino-5-Fluoropyridin-4-Yl)Piperidine-4-Carboxylate is used as a building block in the synthesis of new materials with specific properties. Its versatile structure may allow for the creation of materials with tailored characteristics for use in various applications, such as in electronics or advanced materials research.

Upstream product

• 10314-98-4 1-benzyloxycarbonylpiperidine-4-carboxylic acid 
• 882738-24-1 1-benzyl 4-tert-butyl piperidine-1,4-dicarboxylate 
• 138007-24-6 4-tert-butyl piperidine-4-carboxylate 
• 1613193-36-4 tert-butyl 1-(3-bromo-5-fluoro-4-pyridyl)piperidine-4-carboxylate 
• 1613192-96-3 3-bromo-4-chloro-5-fluoropyridine hydrochloride 
• 1211540-92-9 3-bromo-4-chloro-5-fluoropyridine 
• 407-20-5 3-bromo-5-fluoropyridine 

Downstream Products

• 1613191-99-3 2-amino-6-fluoro-N-[5-fluoro-4-(4-{[4-(oxetan-3-yl)piperazin-1-yl]carbonyl}piperidin-1-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 

Relevant articles and documents

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention. The compounds of this invention have formula I-A or I-B: wherein the variables are as defined herein.

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I) or a pharmaceutically acceptable salt, wherein the variables are as devined herein. Moreover, The compounds of this invention have formula (I-A) or a pharmaceutically acceptable salt, wherein the variables are as defined herein.